A glimpse into the future of TAVR

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Surgical Innovation

Background:

• Significant variations persist in Transcatheter Aortic Valve Replacement (TAVR) patient management protocols between Europe and the USA.
• Key differences include the roles of cardiovascular surgeons and imaging cardiologists, utilization of transesophageal echocardiography (TEE), general anesthesia with endotracheal intubation, and inpatient length of stay.

Discussion:

• These management disparities suggest distinct approaches to TAVR implementation and procedural evolution.
• The provisional involvement of surgical teams and the extent of echocardiographic guidance are critical factors influencing TAVR practice.

Key Insights:

• European TAVR practices are evolving towards reduced reliance on immediate cardiovascular surgeon presence.
• Advanced imaging guidance, such as TEE, may become less standardized in future US TAVR procedures.
• The length of hospital stay is another area where practices diverge, potentially impacting resource utilization and patient recovery.

Outlook:

• The US TAVR landscape is anticipated to shift, potentially adopting models similar to European practices with less mandatory surgical backup.
• Expect a trend towards TAVR procedures performed with limited echocardiographic imaging guidance in the USA.
• These changes could redefine the operational and clinical framework for TAVR in the United States.